PINK1 and Parkinson disease: Niclosamide has been used safely in humans for over half a century to treat helminth infections and is currently being tested in multiple clinical trials in a variety of human cancers, as well as rheumatoid arthritis.19 Our data suggests that niclosamide and/or its analogues could have therapeutic benefit in slowing down PD progression through the activation of PINK1.